APOL1 and chronic kidney disease: APOL1 variants account for much of the increased risk of non-diabetic chronic kidney disease and end-stage renal disease in West African populations (Tayo et al. 2013, Ulasi et al. 2013) and in African Americans (Genovese et al. 2010, Tzur et al. 2010).